DMCC Speciality Chemicals Q1 FY23: Revenue ₹113.39 Cr, EBITDA margin 13.79%
Q1 FY23 investor presentation: what the company reported on revenue, margins and capex.
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
DMCC Speciality Chemicals Ltd Q1 FY23 key numbers
- Revenue
- EBITDA: ₹15.64 crore, increased 22.28% YoY.
As stated in DMCC Speciality Chemicals Ltd's Q1 FY23 investor presentation · published 24 Sept 2026. Reported figures, not investment advice.
Based on DMCC Speciality Chemicals Ltd's Q1 FY23 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q1 FY23 Revenue from Operations: ₹113.39 crore, up 60.50% YoY. EBITDA (Including Other Income): ₹15.64 crore in Q1 FY23, up 22.28% YoY - EBITDA Margin: 13.79% in Q1 FY23, down 431 basis points YoY - Profit After Taxes (PAT): ₹6.23 crore in Q1 FY23, down 17.15% YoY Margin Outlook: - The management mentions approaching optimal capacity utilisation in bulk chemicals, with volume growth expected from expansion completion.
From DMCC Speciality Chemicals Ltd's Q1 FY23 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q1 FY23 Revenue from Operations: ₹113.39 crore, up 60.50% YoY.
- Q1 FY23 Total Income: ₹114.16 crore, up 57.55% YoY.
- EBITDA: ₹15.64 crore, increased 22.28% YoY.
- Profit After Taxes: ₹6.23 crore, down 17.15% YoY.
- Sales split: 77% domestic, 23% export.
- Sales by product: 60% bulk chemicals, 40% specialty chemicals.
- Management remarks note moderate volume growth in Q1FY23, with slow domestic demand muting volume increases.
- Outlook: Strong volumetric growth expected in FY23 as the second phase of expansion nears completion.
2 more points from DMCC Speciality Chemicals Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
EBITDA (Including Other Income): ₹15.64 crore in Q1 FY23, up 22.28% YoY
Locked: what DMCC Speciality Chemicals Ltd said on margins
Also locked on this page: fundraising, order book
Free account, 30 seconds. No card needed.
Capital Expenditure Plans
- Debottlenecking at Roha
- Investment: ~₹10 crores
- Status: Complete
- Two Multipurpose Plants at Dahej
- Investment: ~₹10 crores
- Status: Complete; commercial production started
- Bulk Chemicals Capacity Expansion at Dahej
- Investment: ₹50 crores
- Status: Complete; commercial production started
- Dedicated Speciality Chemicals Plant at Dahej
- Investment: ₹20 crores
- Status: Expected to start commercial production by Q2 FY23
- Note: Products to be manufactured are confidential due to NDA
- Intermediates Plant Expansion at Dahej
- Investment: ₹20 crores
- Status: Complete; commercial production started
- Investment in Sulfones plant
2 more points from DMCC Speciality Chemicals Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
There is no direct reference to changes in borrowings or net debt in the presentation.
Locked: what DMCC Speciality Chemicals Ltd said on fundraising
Also locked on this page: margins, order book
Free account, 30 seconds. No card needed.
Order Book & Pipeline
See what DMCC Speciality Chemicals Ltd said on order book & pipeline — free account, 30 seconds.
DMCC Speciality Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹273 Cr, net profit ₹3 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What DMCC Speciality's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Gujarat Alkalies (Q1 FY23)
1,106.62 crores (Net External Sales Value, page 9) . Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q1 FY23 earnings call — and how it ranks…
- GOCL Corporation (Q1 FY23)
Q1-FY23 Total Income: INR 4,866 Mn (compared to INR 1,756 Mn in Q1-FY22) — significant increase, exact YoY % not provided but roughly +177%. Key concall…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
DMCC Speciality Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were DMCC Speciality Chemicals Ltd Q1 FY23 results?
Q1 FY23 Revenue from Operations: ₹113.39 crore, up 60.50% YoY. EBITDA (Including Other Income): ₹15.64 crore in Q1 FY23, up 22.28% YoY - EBITDA Margin: 13.79% in Q1 FY23, down 431 basis points YoY - Profit After Taxes (PAT): ₹6.23 crore in Q1 FY23, down 17.15% YoY Margin Outlook: - The management mentions approaching optimal capacity utilisation in bulk chemicals, with volume growth expected from expansion completion.
What is DMCC Speciality Chemicals Ltd share price analysis?
DMCC Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 17.5 with a market cap of ₹700 Cr. Investors should review the full earnings analysis for detailed insights.
Is DMCC Speciality Chemicals Ltd planning capital expenditure?
Debottlenecking at Roha - Investment: ~₹10 crores - Status: Complete - Two Multipurpose Plants at Dahej - Investment: ~₹10 crores - Status: Complete; commercial production sta
Keep DMCC Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
